Back
ResMed 10K Form
Sell
17
RSMDF
ResMed
Last Price:
17.70
Seasonality Move:
6.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-13 | 10K | RSMDF/ResMed Annual |
2020-05-01 | 10Q | RSMDF/ResMed Quarterly |
2020-01-31 | 10Q | RSMDF/ResMed Quarterly |
2019-10-25 | 10Q | RSMDF/ResMed Quarterly |
2019-08-08 | 10K | RSMDF/ResMed Annual |
2019-05-03 | 10Q | RSMDF/ResMed Quarterly |
Receive RSMDF News And Ratings
See the #1 stock for the next 7 days that we like better than RSMDF
RSMDF Financial Statistics
Sales & Book Value
Annual Sales: | $4.22B |
---|---|
Cash Flow: | $378.92M |
Price / Cash Flow: | 24.37 |
Annual Sales: | $3.15 |
Price / Book: | 5.62 |
Profitability
EPS (TTM): | 0.65100 |
---|---|
Net Income (TTM): | $958.38M |
Gross Margin: | $2.36B |
Return on Equity: | 22.37% |
Return on Assets: | 14.13% |
ResMed Earnings Forecast
Key ResMed Financial Ratios
- The Gross Profit Margin over the past 31 years for RSMDF is 55.78%.
- The Selling, General & Administrative Expenses for RSMDF have been equal to 20.70% of Gross Profit Margin.
- The Research & Development expenses have been 6.81% of Revenue.
- The Interest Expense is 5.06% of Operating Income.
- The Net Earning history of RSMDF is 21.25% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 24 years.
ResMed Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | RSMDF |
Website: | resmed.com |
Debt
Debt-to-Equity Ratio: | 0.22 |
---|---|
Current Ratio: | 3.04 |
Quick Ratio: | 1.32 |
Price-to-Earnings
Trailing P/E Ratio: | 29.06 |
---|---|
Forward P/E Ratio: | 0 |